On Aug 5, 2021 Aardvark Therapeutics closed a Series B round and raised $29,000,000 from BNH, Korea Omega Investment, Premier Partners, Sorrento Therapeutics, The Foundation for Prader-Willi Research, Vickers Venture Partners, featuring lead investors Sorrento Therapeutics.
About the company: Aardvark Therapeutics is located at United States, North America.
“”
Company website: aardvarktherapeutics.com/